[1]
A. Wolszczak, “SARCOPENIC OBESITY IN THE ERA OF INCRETIN-BASED THERAPIES: DIAGNOSTIC CHALLENGES, THE RISK OF MUSCLE MASS LOSS, AND PREVENTION STRATEGIES”, IJITSS, vol. 1, no. 3(51), Aug. 2026, doi: 10.31435/ijitss.3(51).2026.5940.